Lamotrigine Award

SOL #: SPE2D2-25-D-0013Award Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Brookhaven, NY

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
May 5, 2025
2
Last Updated
Apr 28, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Logistics Agency (DLA) Troop Support has awarded contract SPE2D2-25-D-0013 to AVKARE, LLC for pharmaceutical prime vendor services providing Lamotrigine ER tablets. This award, with an estimated total value of $15,978,181.35 over five years, has recently seen the execution of Option Year 1, covering the period from May 13, 2026, through May 12, 2027.

Scope of Work

The contract requires the procurement and supply of Lamotrigine ER tablets in various dosages (25mg, 50mg, 100mg, 200mg, 250mg, and 300mg), provided in 30-count bottles. This encompasses pharmaceutical prime vendor services to ensure the availability of these critical medications for the Department of Defense.

Contract & Timeline

  • Contract Number: SPE2D2-25-D-0013
  • Awarded Contractor: AVKARE, LLC
  • Estimated Total Value: $15,978,181.35
  • Duration: Base year plus four option years (5 years total)
  • Option Year 1 Period: May 13, 2026 – May 12, 2027
  • Set-Aside: Unrestricted
  • NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing)
  • Published Date: April 28, 2026 (Modification)

Award Details

The initial award stemmed from Solicitation Number SPE2D2-25-R-0002. AVKARE, LLC submitted an offer on January 9, 2025, with a final proposal revision on April 18, 2025, which was subsequently accepted. The contract incorporates FAR 52.212-1, 52.212-3, and 52.212-5 by reference.

Additional Notes

The contract includes extensive FAR and DFARS clauses covering various requirements, including small business concerns, labor standards, trade agreements, and supply chain security. The place of performance is Brookhaven, NY.

People

Points of Contact

Nancy FernandezPRIMARY
Jason C. WraySECONDARY

Files

Files

Download
Download

Versions

Version 2Viewing
Award Notice
Posted: Apr 28, 2026
Version 1
Award Notice
Posted: May 5, 2025
View
Lamotrigine Award | GovScope